Ginkgo Bioworks Inc. (DNA)

DNA trades at $16.14, 46.7% above the near-term max pain of $11 expiring Oct 17, 2025 (12 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($7-$12), reflecting growing call interest at higher strikes. Key magnetic zone at 7 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for DNA shows an upward trend from 7 to 12, suggesting bullish positioning in longer-dated options. The 52% spread signals divergent expectations across timeframes. Most levels below 16.14 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.